Full-Time

Senior Product Marketing Manager

Plaque

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Healthcare

Compensation Overview

$103k - $165kAnnually

+ Cash Bonus + Stock Options

Senior

Austin, TX, USA + 1 more

More locations: Remote in USA

Remote option available.

Category
Product Marketing
Product
Requirements
  • Proven ability to establish/set marketing strategy and drive execution.
  • Critical and analytical thinking to solve business challenges.
  • Self-motivated, flexible, and entrepreneurial
  • Excellent presentation, written, and verbal communication skills.
  • Strong interpersonal skills and proven ability to collaborate and work cross-functionally to drive results.
Responsibilities
  • Understand the patient journey and cultivate deep understanding of customer needs, competitive dynamics, and market opportunities.
  • Customize HeartFlow Plaque Analysis value propositions, positioning, key messages, and assets to drive adoption and utilization.
  • Understand barriers-to-adoption, work cross-functionally to formulate strategies and develop plans to break down these barriers to maximize success.
  • Collaborate across Marketing to ensure cohesive marketing plan.
  • Collaborate with Marketing Communications to build and execute the omnichannel strategy reach target customer segments.
  • Collaborate with Sales Training to build content for continued education of the salesforce.
  • Collaborate with Medical Affairs to build thought leadership content.
  • Partner closely with Sales leadership and Field Advisory Board to develop effective tools for salesforce to achieve results.
  • Closely manage timelines across all activities to drive execution.
  • Set metrics and take a data-driven approach to measure the effectiveness of the marketing programs.
Desired Qualifications
  • Experience within a start-up environment preferred.
  • Experience in cardiology preferred.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow closed a $215 million Series F funding round in April 2023.
  • The global non-invasive cardiac imaging market is projected to grow significantly.
  • HeartFlow's technology aligns with the trend towards value-based care in healthcare.

What critics are saying

  • Emerging AI-driven competitors could threaten HeartFlow's market share.
  • Algorithmic bias in AI models could lead to inaccurate diagnoses.
  • Integration into healthcare systems may face resistance due to complexity and cost.

What makes HeartFlow unique

  • HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
  • HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
  • HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match